Iannazzo, Sergio, Edoardo Mannucci, and Lorenzo Mantovani. 2016. “[Budget Impact Analysis of Empagliflozin for the Treatment of Type 2 Diabetes in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways 17 (1):19-27. https://doi.org/10.7175/fe.v17i1.1238.